Sign Up for Keystone Heart Updates

(972) 4-615-8000

info@keystoneheart.com

Search

Who We Are
Patients
- Patient Information
- Frequently Asked Questions (FAQs)
Healthcare Professionals
- Interviews
- Videos
Products
- TriGUARD 3™ CEP Device Technology
- Instructions For Use
Clinical Evidence
News

Who We Are
Patients
- Patient Information
- Frequently Asked Questions (FAQs)
Healthcare Professionals
- Interviews
- Videos
Products
- TriGUARD 3™ CEP Device Technology
- Instructions For Use
Clinical Evidence
News

Search:

Lin PJ

Lin PJ, Neumann PJ. The economics of mild cognitive impairment. Alzheimers Dement 2013;9:58-62.

Abstracts Categories

Technology
Delirium
Silent Cerebrovascular Events
Diffusion-weighted magnetic resonance imaging (DW-MRI)
Stroke
Cerebrovascular Events & TAVR
Quality of Life
Healthcare Economics

Recent Abstracts

Zimpfer D
Wityk RJ

A Venus Medtech Company

Important Links

About Us
Clinical Evidence
Patients
Presentations
Products
News
Careers
Contact Us

Disclaimer

The TriGUARD 3™ Cerebral Embolic Protection Device is CE marked. Approved for investigational use only in the US, not cleared by the US FDA.

“TriGUARD cerebral Embolic Protection Device” and TriGUARD 3™ cerebral Embolic Protection Device are trademarks owned by Keystone Heart, LTD. and may be registered. All other trademarks are the property of their respective owners.

Copyright Keystone Heart, A Venus Medtech Company 2021

Privacy Policy
Disclaimer

Site By Tarika Technologies™